Insitu Biologics, Inc.

Exited
CIK: 1723443•DE•Tier2

Equity (common or preferred stock) · Audited · Healthcare · SIC 2836

$10M
Qualified
maximum offering price, as qualified
$3.9M
Reported Sold
1-Z 2020-12-30
11
Filings
across 2 offerings

Equity Classes

TypeClassOutstanding
commonCommon Stock0

Service Providers

RoleProvider
auditorLLP
legalTrowbridge Sidoti LLP
promoterFundAthena, Inc.
sales commissionLLC

Offerings

File NumberFilingsFirst FiledLast FiledQualifiedPrice/SecuritySecurities OfferedOutstandingAggregate OfferingIssuer PortionSelling HoldersPrior 12mo QualifiedConcurrent OfferingEstimated NetSupplementsLast Supplement
024-1084582018-06-052019-03-272019-03-27$8.00916,6726,311,514$10M$7.3M$0$2.7M$0$10M62019-10-21

Reporting & Exit

Filed under the issuer’s Regulation A reporting number

File NumberFormFiledSales CommencedSecurities SoldQualified Sold
24R-001691-Z2020-12-302019-03-273,921,99810,000,010

Current Reports

Filing DateFormEventItems
2019-09-031-UChange in Control6,7
Embarc dashboard

Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.

  • Every caption as the filer wrote it, across every annual report — not just the latest 1-K
  • Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
  • A sparkline on each annual-statement line, so the shape is visible before the figures
  • A revenue series dated to the filings that reported it
  • A filing history that says what each document contributed, not only that it exists
  • Follow it, and see it change on your watchlist
Open in the dashboard
External link: SEC Filings